Adverse effect of Canaglifloxacin on bone is reversed by Puerariae radix in rat model of diabetics

Abstract

The root of Pueraria labata, Puerariae radix(PR), a leguminous plant that grows wild, is one of the first and most significant basic herbs used in traditional medicine for a variety of therapeutic uses. PR is high in isoflavonoids including daidzein and genistein, which have been shown to protect against bone loss caused by oestrogen insufficiency. In an osteoporotic animal model, soybean isoflavones have been shown to reduce bone loss. CGF (canagliflozin) appears to raise the risk of fractur. In diabetic rats, the potential function of PR in reversing CGFinduced bone loss was investigated. A rat model was used to investigate the effects of Puerariae radix extract (PRE) on blood glucose, HBA1C levels, and bone mineral density. Control group (vehicle therapy), Diabetic group, `PRE group, Canagliflozin (CGF), and CGF +PRE group were all made up of six Wistar albino rats. Each medication was given by gastric gavage once a day for 35 days. PRE treatment increased bone mass substantially when compared to normal controls. This suggests that PRE might be developed as an alternative therapy for osteoporosis caused by anti-diabetic drugs. Keywords: Puerariae radix, Diabetic osteoporosis, streptozotocin, Canagliflozin.